Trending Articles

  1. Clean Cells expands biopharma analytics with Anaquant acquisition The purchase adds mass spectrometry-based protein characterisation and HCP analysis to Clean Cells’ GMP testing platform, creating an end-to-end analytical offering for...
  2. Lonza and Engitix announce license agreement to advance targeted ADC Development Lonza grants Engitix target-specific license for GlycoConnect, HydraSpace and SYNtecan E linker-payload technologies for ADC development
  3. DNA Script and GE Healthcare awarded $26m ARPA-H funding to scale cell-free DNA bioproduction The pair will combine DNA Script's EDS technology with GE HealthCare's DNA scaling technology to create a faster, more flexible manufacturing process for cell-free DNA as the...
  4. Digitalisation: more space for research and development in Salzburg, Austria COPA-DATA is investing €15 million in the project, underlining its long-term commitment to Salzburg and Austria as a location for technology, research and innovation
  5. AstraZeneca-BMS $400bn merger could reshape US pharma manufacturing A potential AstraZeneca acquisition of Bristol Myers Squibb would create a near-$400bn pharma giant, combining major oncology portfolios and extensive US manufacturing operations

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all

You may also like

Manufacturing The pair will combine DNA Script's EDS technology with GE HealthCare's DNA scaling technology to create a faster, more flexible manufacturing process for cell-free DNA as the...
DNA Script and GE Healthcare awarded $26m ARPA-H funding to scale cell-free DNA bioproduction

DNA Script and GE Healthcare awarded $26m ARPA-H funding to scale cell-free DNA bioproduction

Read more
Research & Development COPA-DATA is investing €15 million in the project, underlining its long-term commitment to Salzburg and Austria as a location for technology, research and innovation
Digitalisation: more space for research and development in Salzburg, Austria

Digitalisation: more space for research and development in Salzburg, Austria

Read more
Finance The Series C financing will support clinical development of Ratio’s Ac-225 radiotherapeutic pipeline and expansion of its radiopharmaceutical manufacturing infrastructure
Ratio Therapeutics raises $70m to expand radiopharmaceutical manufacturing

Ratio Therapeutics raises $70m to expand radiopharmaceutical manufacturing

Read more
Finance A potential AstraZeneca acquisition of Bristol Myers Squibb would create a near-$400bn pharma giant, combining major oncology portfolios and extensive US manufacturing operations
AstraZeneca-BMS $400bn merger could reshape US pharma manufacturing

AstraZeneca-BMS $400bn merger could reshape US pharma manufacturing

Read more
Finance The purchase adds mass spectrometry-based protein characterisation and HCP analysis to Clean Cells’ GMP testing platform, creating an end-to-end analytical offering for...
Clean Cells expands biopharma analytics with Anaquant acquisition

Clean Cells expands biopharma analytics with Anaquant acquisition

Read more
Finance The Molten Ventures-led round funds a 3D chest imaging Foundation Model laboratory and commercial expansion, building on Qureight's established lung fibrosis CRO capabilities...
Qureight raises $20m Series B to expand AI imaging platform into asthma, pulmonary hypertension and bronchiectasis

Qureight raises $20m Series B to expand AI imaging platform into asthma, pulmonary hypertension and bronchiectasis

Read more
Finance Significant optimisation of the capital and financing structure through expected cash inflows, meaningfully decreasing leverage
Gerresheimer is selling Centor and its global Primary Packaging Plastics business to Apax Funds

Gerresheimer is selling Centor and its global Primary Packaging Plastics business to Apax Funds

Read more
Research & Development Celonic and Leukocare partner to combine bioprocessing and GMP manufacturing with data-driven formulation expertise for complex biologics
Celonic and Leukocare to help clients with complex biologics and advanced drug product profiles

Celonic and Leukocare to help clients with complex biologics and advanced drug product profiles

Read more
Research & Development This partnership builds upon ProBioGen's extensive expertise in coagulation factor development, including successful programmes with Factor VII and Factor VIII therapeutics
ProBioGen and VarmX announce collaboration for advanced cell line development

ProBioGen and VarmX announce collaboration for advanced cell line development

Read more
Finance The €20m deal adds Lambert's 50-year complex assembly and filling automation expertise in Tadcaster to Mechitronic's 15-brand network, strengthening the group's UK pharma...
Mechitronic acquires Lambert to strengthen pharma and medtech assembly platform

Mechitronic acquires Lambert to strengthen pharma and medtech assembly platform

Read more
Manufacturing An experienced international HR leader, Alawi joins DFE Pharma’s Leadership Team to support the company’s people-centric, high-performance culture
DFE Pharma appoints Khatera Alawi as new Global Director Human Resources

DFE Pharma appoints Khatera Alawi as new Global Director Human Resources

Read more
Manufacturing Exclusive Frankfurt event to bring together senior pharma supply chain leaders, digital transformation specialists and technology partners
LogiPharma Digital Supply Chain Connect announces 2026 agenda for pharma supply chain summit

LogiPharma Digital Supply Chain Connect announces 2026 agenda for pharma supply chain summit

Read more
Manufacturing Lonza grants Engitix target-specific license for GlycoConnect, HydraSpace and SYNtecan E linker-payload technologies for ADC development
Lonza and Engitix announce license agreement to advance targeted ADC Development

Lonza and Engitix announce license agreement to advance targeted ADC Development

Read more
Manufacturing Andreas Reisse to retire as CEO of SCHOTT Pharma as planned. Christian Mias, Executive Vice President of SCHOTT’s Electronic Packaging Business Unit, appointed as new CEO of...
Christian Mias to succeed Andreas Reisse as CEO of SCHOTT Pharma

Christian Mias to succeed Andreas Reisse as CEO of SCHOTT Pharma

Read more
Manufacturing The manufacturer is set to acquire peptide CDMO PolyPeptide for CHF 1.46bn, expanding its manufacturing capabilities into peptide APIs and strengthening its global footprint...
Samsung Biologics to acquire PolyPeptide in $1.8bn deal

Samsung Biologics to acquire PolyPeptide in $1.8bn deal

Read more
Research & Development Cambridge-based biotech Mission Therapeutics has divested its Phase II-ready USP30 inhibitor MTX652 to renal specialist Dimerix in a deal worth up to $292m, allowing the...
Mission Therapeutics divests acute kidney injury drug MTX652 in $292m Dimerix deal

Mission Therapeutics divests acute kidney injury drug MTX652 in $292m Dimerix deal

Read more